Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Journal of Clinical Psychopharmacology
|
December 24, 1998
Gabapentin does not alter single-dose lithium pharmacokinetics
M A Frye, T A Kimbrell, R T Dunn, et al.
The Journal of Clinical Psychiatry
|
September 15, 1999
Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder
T R Goldstein, M A Frye, K D Denicoff, et al.
The American Journal of Psychiatry
|
December 10, 1999
Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients
M A Frye, K D Denicoff, A L Bryan, et al.
Biological Psychiatry
|
December 1, 1999
Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders
T A Ketter, T A Kimbrell, M S George, et al.
Bipolar Disorders
|
March 17, 2001
Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review
R M Post, M A Frye, K D Denicoff, et al.
Acta Psychiatrica Scandinavica
|
February 3, 2009
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
M A Frye, L Yatham, T A Ketter, et al.
Journal of Neurochemistry
|
April 1, 1996
Increased neural cell adhesion molecule in the CSF of patients with mood disorder
M Poltorak, M A Frye, R Wright, et al.
Psychopharmacology
|
November 1, 1996
The place of anticonvulsant therapy in bipolar illness
R M Post, T A Ketter, K Denicoff, et al.
Journal of Affective Disorders
|
April 9, 2014
More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment
R M Post, L Altshuler, R Kupka, et al.
Translational Psychiatry
|
December 10, 2015
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders
M A Frye, M Nassan, G D Jenkins, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Journal of Clinical Psychopharmacology
|
December 24, 1998
Gabapentin does not alter single-dose lithium pharmacokinetics
M A Frye, T A Kimbrell, R T Dunn, et al.
The Journal of Clinical Psychiatry
|
September 15, 1999
Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder
T R Goldstein, M A Frye, K D Denicoff, et al.
The American Journal of Psychiatry
|
December 10, 1999
Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients
M A Frye, K D Denicoff, A L Bryan, et al.
Biological Psychiatry
|
December 1, 1999
Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders
T A Ketter, T A Kimbrell, M S George, et al.
Bipolar Disorders
|
March 17, 2001
Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review
R M Post, M A Frye, K D Denicoff, et al.
Acta Psychiatrica Scandinavica
|
February 3, 2009
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
M A Frye, L Yatham, T A Ketter, et al.
Journal of Neurochemistry
|
April 1, 1996
Increased neural cell adhesion molecule in the CSF of patients with mood disorder
M Poltorak, M A Frye, R Wright, et al.
Psychopharmacology
|
November 1, 1996
The place of anticonvulsant therapy in bipolar illness
R M Post, T A Ketter, K Denicoff, et al.
Journal of Affective Disorders
|
April 9, 2014
More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment
R M Post, L Altshuler, R Kupka, et al.
Translational Psychiatry
|
December 10, 2015
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders
M A Frye, M Nassan, G D Jenkins, et al.
Page
of 8